Table of Contents United States Bronchitis Drug Market Report 2017 1 Bronchitis Drug Overview 1.1 Product Overview and Scope of Bronchitis Drug 1.2 Classification of Bronchitis Drug by Product Category 1.2.1 United States Bronchitis Drug Market Size (Sales Volume) Comparison by Type (2012-2022) 1.2.2 United States Bronchitis Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016 1.2.3 AZD-9668 1.2.4 CG-367 1.2.5 Cyclosporine 1.2.6 HOB-051 1.2.7 Others 1.3 United States Bronchitis Drug Market by Application/End Users 1.3.1 United States Bronchitis Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Homecare 1.4 United States Bronchitis Drug Market by Region 1.4.1 United States Bronchitis Drug Market Size (Value) Comparison by Region (2012-2022) 1.4.2 The West Bronchitis Drug Status and Prospect (2012-2022) 1.4.3 Southwest Bronchitis Drug Status and Prospect (2012-2022) 1.4.4 The Middle Atlantic Bronchitis Drug Status and Prospect (2012-2022) 1.4.5 New England Bronchitis Drug Status and Prospect (2012-2022) 1.4.6 The South Bronchitis Drug Status and Prospect (2012-2022) 1.4.7 The Midwest Bronchitis Drug Status and Prospect (2012-2022) 1.5 United States Market Size (Value and Volume) of Bronchitis Drug (2012-2022) 1.5.1 United States Bronchitis Drug Sales and Growth Rate (2012-2022) 1.5.2 United States Bronchitis Drug Revenue and Growth Rate (2012-2022) 2 United States Bronchitis Drug Market Competition by Players/Suppliers 2.1 United States Bronchitis Drug Sales and Market Share of Key Players/Suppliers (2012-2017) 2.2 United States Bronchitis Drug Revenue and Share by Players/Suppliers (2012-2017) 2.3 United States Bronchitis Drug Average Price by Players/Suppliers (2012-2017) 2.4 United States Bronchitis Drug Market Competitive Situation and Trends 2.4.1 United States Bronchitis Drug Market Concentration Rate 2.4.2 United States Bronchitis Drug Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Bronchitis Drug Manufacturing Base Distribution, Sales Area, Product Type 3 United States Bronchitis Drug Sales (Volume) and Revenue (Value) by Region (2012-2017) 3.1 United States Bronchitis Drug Sales and Market Share by Region (2012-2017) 3.2 United States Bronchitis Drug Revenue and Market Share by Region (2012-2017) 3.3 United States Bronchitis Drug Price by Region (2012-2017) 4 United States Bronchitis Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017) 4.1 United States Bronchitis Drug Sales and Market Share by Type (Product Category) (2012-2017) 4.2 United States Bronchitis Drug Revenue and Market Share by Type (2012-2017) 4.3 United States Bronchitis Drug Price by Type (2012-2017) 4.4 United States Bronchitis Drug Sales Growth Rate by Type (2012-2017) 5 United States Bronchitis Drug Sales (Volume) by Application (2012-2017) 5.1 United States Bronchitis Drug Sales and Market Share by Application (2012-2017) 5.2 United States Bronchitis Drug Sales Growth Rate by Application (2012-2017) 5.3 Market Drivers and Opportunities 6 United States Bronchitis Drug Players/Suppliers Profiles and Sales Data 6.1 Advanced Inhalation Therapies (AIT) Ltd 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Bronchitis Drug Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 AstraZeneca Plc 6.2.2 Bronchitis Drug Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 AstraZeneca Plc Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 DBV Technologies SA 6.3.2 Bronchitis Drug Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 DBV Technologies SA Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 F. Hoffmann-La Roche Ltd 6.4.2 Bronchitis Drug Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 F. Hoffmann-La Roche Ltd Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Han Wha Pharma Co Ltd 6.5.2 Bronchitis Drug Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Han Wha Pharma Co Ltd Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Kyorin Pharmaceutical Co Ltd 6.6.2 Bronchitis Drug Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Kyorin Pharmaceutical Co Ltd Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Merck & Co Inc 6.7.2 Bronchitis Drug Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Merck & Co Inc Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Mucosis BV 6.8.2 Bronchitis Drug Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Mucosis BV Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Orbis Biosciences Inc 6.9.2 Bronchitis Drug Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Orbis Biosciences Inc Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 Therabron Therapeutics Inc 6.10.2 Bronchitis Drug Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Therabron Therapeutics Inc Bronchitis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 7 Bronchitis Drug Manufacturing Cost Analysis 7.1 Bronchitis Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Bronchitis Drug 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Bronchitis Drug Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Bronchitis Drug Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Bronchitis Drug Market Size (Value and Volume) Forecast (2017-2022) 11.1 United States Bronchitis Drug Sales Volume, Revenue Forecast (2017-2022) 11.2 United States Bronchitis Drug Sales Volume Forecast by Type (2017-2022) 11.3 United States Bronchitis Drug Sales Volume Forecast by Application (2017-2022) 11.4 United States Bronchitis Drug Sales Volume Forecast by Region (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Bronchitis Drug Figure United States Bronchitis Drug Market Size (K Pcs) by Type (2012-2022) Figure United States Bronchitis Drug Sales Volume Market Share by Type (Product Category) in 2016 Figure AZD-9668 Product Picture Figure CG-367 Product Picture Figure Cyclosporine Product Picture Figure HOB-051 Product Picture Figure Others Product Picture Figure United States Bronchitis Drug Market Size (K Pcs) by Application (2012-2022) Figure United States Sales Market Share of Bronchitis Drug by Application in 2016 Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Homecare Examples Table Key Downstream Customer in Homecare Figure United States Bronchitis Drug Market Size (Million USD) by Region (2012-2022) Figure The West Bronchitis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure Southwest Bronchitis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure The Middle Atlantic Bronchitis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure New England Bronchitis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure The South of US Bronchitis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure The Midwest Bronchitis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Bronchitis Drug Sales (K Pcs) and Growth Rate (2012-2022) Figure United States Bronchitis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Bronchitis Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017) Table United States Bronchitis Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017) Table United States Bronchitis Drug Sales Share by Players/Suppliers (2012-2017) Figure 2016 United States Bronchitis Drug Sales Share by Players/Suppliers Figure 2017 United States Bronchitis Drug Sales Share by Players/Suppliers Figure United States Bronchitis Drug Market Major Players Product Revenue (Million USD) (2012-2017) Table United States Bronchitis Drug Revenue (Million USD) by Players/Suppliers (2012-2017) Table United States Bronchitis Drug Revenue Share by Players/Suppliers (2012-2017) Figure 2016 United States Bronchitis Drug Revenue Share by Players/Suppliers Figure 2017 United States Bronchitis Drug Revenue Share by Players/Suppliers Table United States Market Bronchitis Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017) Figure United States Market Bronchitis Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016 Figure United States Bronchitis Drug Market Share of Top 3 Players/Suppliers Figure United States Bronchitis Drug Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Bronchitis Drug Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Bronchitis Drug Product Category Table United States Bronchitis Drug Sales (K Pcs) by Region (2012-2017) Table United States Bronchitis Drug Sales Share by Region (2012-2017) Figure United States Bronchitis Drug Sales Share by Region (2012-2017) Figure United States Bronchitis Drug Sales Market Share by Region in 2016 Table United States Bronchitis Drug Revenue (Million USD) and Market Share by Region (2012-2017) Table United States Bronchitis Drug Revenue Share by Region (2012-2017) Figure United States Bronchitis Drug Revenue Market Share by Region (2012-2017) Figure United States Bronchitis Drug Revenue Market Share by Region in 2016 Table United States Bronchitis Drug Price (USD/Pcs) by Region (2012-2017) Table United States Bronchitis Drug Sales (K Pcs) by Type (2012-2017) Table United States Bronchitis Drug Sales Share by Type (2012-2017) Figure United States Bronchitis Drug Sales Share by Type (2012-2017) Figure United States Bronchitis Drug Sales Market Share by Type in 2016 Table United States Bronchitis Drug Revenue (Million USD) and Market Share by Type (2012-2017) Table United States Bronchitis Drug Revenue Share by Type (2012-2017) Figure Revenue Market Share of Bronchitis Drug by Type (2012-2017) Figure Revenue Market Share of Bronchitis Drug by Type in 2016 Table United States Bronchitis Drug Price (USD/Pcs) by Types (2012-2017) Figure United States Bronchitis Drug Sales Growth Rate by Type (2012-2017) Table United States Bronchitis Drug Sales (K Pcs) by Application (2012-2017) Table United States Bronchitis Drug Sales Market Share by Application (2012-2017) Figure United States Bronchitis Drug Sales Market Share by Application (2012-2017) Figure United States Bronchitis Drug Sales Market Share by Application in 2016 Table United States Bronchitis Drug Sales Growth Rate by Application (2012-2017) Figure United States Bronchitis Drug Sales Growth Rate by Application (2012-2017) Table Advanced Inhalation Therapies (AIT) Ltd Basic Information List Table Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Sales Growth Rate (2012-2017) Figure Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Sales Market Share in United States (2012-2017) Figure Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Revenue Market Share in United States (2012-2017) Table AstraZeneca Plc Basic Information List Table AstraZeneca Plc Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure AstraZeneca Plc Bronchitis Drug Sales Growth Rate (2012-2017) Figure AstraZeneca Plc Bronchitis Drug Sales Market Share in United States (2012-2017) Figure AstraZeneca Plc Bronchitis Drug Revenue Market Share in United States (2012-2017) Table DBV Technologies SA Basic Information List Table DBV Technologies SA Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure DBV Technologies SA Bronchitis Drug Sales Growth Rate (2012-2017) Figure DBV Technologies SA Bronchitis Drug Sales Market Share in United States (2012-2017) Figure DBV Technologies SA Bronchitis Drug Revenue Market Share in United States (2012-2017) Table F. Hoffmann-La Roche Ltd Basic Information List Table F. Hoffmann-La Roche Ltd Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure F. Hoffmann-La Roche Ltd Bronchitis Drug Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Ltd Bronchitis Drug Sales Market Share in United States (2012-2017) Figure F. Hoffmann-La Roche Ltd Bronchitis Drug Revenue Market Share in United States (2012-2017) Table Han Wha Pharma Co Ltd Basic Information List Table Han Wha Pharma Co Ltd Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Han Wha Pharma Co Ltd Bronchitis Drug Sales Growth Rate (2012-2017) Figure Han Wha Pharma Co Ltd Bronchitis Drug Sales Market Share in United States (2012-2017) Figure Han Wha Pharma Co Ltd Bronchitis Drug Revenue Market Share in United States (2012-2017) Table Kyorin Pharmaceutical Co Ltd Basic Information List Table Kyorin Pharmaceutical Co Ltd Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Kyorin Pharmaceutical Co Ltd Bronchitis Drug Sales Growth Rate (2012-2017) Figure Kyorin Pharmaceutical Co Ltd Bronchitis Drug Sales Market Share in United States (2012-2017) Figure Kyorin Pharmaceutical Co Ltd Bronchitis Drug Revenue Market Share in United States (2012-2017) Table Merck & Co Inc Basic Information List Table Merck & Co Inc Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Merck & Co Inc Bronchitis Drug Sales Growth Rate (2012-2017) Figure Merck & Co Inc Bronchitis Drug Sales Market Share in United States (2012-2017) Figure Merck & Co Inc Bronchitis Drug Revenue Market Share in United States (2012-2017) Table Mucosis BV Basic Information List Table Mucosis BV Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Mucosis BV Bronchitis Drug Sales Growth Rate (2012-2017) Figure Mucosis BV Bronchitis Drug Sales Market Share in United States (2012-2017) Figure Mucosis BV Bronchitis Drug Revenue Market Share in United States (2012-2017) Table Orbis Biosciences Inc Basic Information List Table Orbis Biosciences Inc Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Orbis Biosciences Inc Bronchitis Drug Sales Growth Rate (2012-2017) Figure Orbis Biosciences Inc Bronchitis Drug Sales Market Share in United States (2012-2017) Figure Orbis Biosciences Inc Bronchitis Drug Revenue Market Share in United States (2012-2017) Table Therabron Therapeutics Inc Basic Information List Table Therabron Therapeutics Inc Bronchitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Therabron Therapeutics Inc Bronchitis Drug Sales Growth Rate (2012-2017) Figure Therabron Therapeutics Inc Bronchitis Drug Sales Market Share in United States (2012-2017) Figure Therabron Therapeutics Inc Bronchitis Drug Revenue Market Share in United States (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Bronchitis Drug Figure Manufacturing Process Analysis of Bronchitis Drug Figure Bronchitis Drug Industrial Chain Analysis Table Raw Materials Sources of Bronchitis Drug Major Players/Suppliers in 2016 Table Major Buyers of Bronchitis Drug Table Distributors/Traders List Figure United States Bronchitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022) Figure United States Bronchitis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure United States Bronchitis Drug Price (USD/Pcs) Trend Forecast (2017-2022) Table United States Bronchitis Drug Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Bronchitis Drug Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Bronchitis Drug Sales Volume (K Pcs) Forecast by Type in 2022 Table United States Bronchitis Drug Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Bronchitis Drug Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Bronchitis Drug Sales Volume (K Pcs) Forecast by Application in 2022 Table United States Bronchitis Drug Sales Volume (K Pcs) Forecast by Region (2017-2022) Table United States Bronchitis Drug Sales Volume Share Forecast by Region (2017-2022) Figure United States Bronchitis Drug Sales Volume Share Forecast by Region (2017-2022) Figure United States Bronchitis Drug Sales Volume Share Forecast by Region in 2022 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources